Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 20,000 shares at $28.01 ($560K) on 2019-10-15, disclosed to the SEC on 2019-10-17.
Open-market sale of $560k HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 10,000 | $280K | 50.0% |
| 2 | $28.01 | 10,000 | $280K | 50.0% |
| Total | $28.00 avg | 20,000 | $560K | 100% |
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |